{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:01:52Z","timestamp":1782363712245,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.crad.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T02:38:51Z","timestamp":1623206331000},"page":"709.e1-709.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein thrombosis: a case\u2013control study"],"prefix":"10.1016","volume":"76","author":[{"given":"A.H.K.","family":"Abdelmaksoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.O.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Nabeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.M.","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.I.","family":"Shousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.M.","family":"Abdelhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2021.03.022_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.crad.2021.03.022_bib2","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3748\/wjg.v21.i13.3843","article-title":"Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma","volume":"21","author":"Song","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crad.2021.03.022_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000367741","article-title":"Locoregional therapy for hepatocellular carcinoma. current status of hepatic arterial infusion chemotherapy","volume":"4","author":"Obi","year":"2015","journal-title":"Liver Canc"},{"key":"10.1016\/j.crad.2021.03.022_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3350\/cmh.2015.21.2.115","article-title":"New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"Woo","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.crad.2021.03.022_bib5","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.3748\/wjg.v21.i12.3462","article-title":"Management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"Quirk","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crad.2021.03.022_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010611","article-title":"Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: a STROBE-compliant article","volume":"97","author":"Kang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.crad.2021.03.022_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2016.07.020","article-title":"Observational registry of sorafenib use in clinical practice across Child\u2013Pugh subgroups: the GIDEON study","volume":"65","author":"Marrero","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.crad.2021.03.022_bib8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American association for the study of liver diseases. Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.crad.2021.03.022_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.crad.2021.03.022_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.crad.2021.03.022_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. a review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.crad.2021.03.022_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crad.2021.03.022_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2021.03.022_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/annonc\/mdm528","article-title":"Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology","volume":"19","author":"Ganeshan","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.crad.2021.03.022_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00535-014-0978-3","article-title":"A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumour thrombosis","volume":"50","author":"Song","year":"2015","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.crad.2021.03.022_bib17","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5009\/gnl.2013.7.6.696","article-title":"Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumour thrombosis","volume":"7","author":"Jeong","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.crad.2021.03.022_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161303","article-title":"Analysis of sorafenib outcome: focusing on the clinical course in patients with hepatocellular carcinoma","volume":"11","author":"Ogasawara","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2021.03.022_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126649","article-title":"A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy","volume":"10","author":"Saeki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2021.03.022_bib20","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/bjc.2013.542","article-title":"Liver cancer study group of Japan. Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the nationwide survey of primary liver cancer in Japan","volume":"109","author":"Nouso","year":"2013","journal-title":"Br J Canc"},{"issue":"9","key":"10.1016\/j.crad.2021.03.022_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1477-2574.2010.00210.x","article-title":"Long term follow up after transarterial chemotherapy for hepatocellular carcinoma in a Scandinavian center","volume":"12","author":"Noren","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"5","key":"10.1016\/j.crad.2021.03.022_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092784","article-title":"Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma","volume":"9","author":"Tsai","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.crad.2021.03.022_bib23","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.2147\/OTT.S156844","article-title":"Transcatheter hepatic arterial infusion chemotherapy vs sorafenib in the treatment of patients with hepatocellular carcinoma of Barcelona Clinic Liver Cancer stage C: a meta-analysis of Asian population","volume":"11","author":"Ni","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.crad.2021.03.022_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00280-018-3638-0","article-title":"Randomized, prospective, comparative study on the effects and safety of sorafenib versus hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumour thrombosis","volume":"82","author":"Choi","year":"2018","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.crad.2021.03.022_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/1751-2980.12267","article-title":"Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma","volume":"16","author":"Kawaoka","year":"2015","journal-title":"J Dig Dis"},{"key":"10.1016\/j.crad.2021.03.022_bib26","first-page":"855","article-title":"Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis","volume":"845","author":"Zhuang","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.crad.2021.03.022_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.21037\/jgo.2018.05.13","article-title":"Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma","volume":"9","author":"Moriya","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.crad.2021.03.022_bib28","first-page":"3555","article-title":"Pilot study of intrahepatic artery chemotherapy in combination with sorafenib in hepatocellular carcinoma","volume":"36","author":"Dinh","year":"2016","journal-title":"Anticanc Res"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021002464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021002464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:43:49Z","timestamp":1757868229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926021002464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0009926021002464"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2021.03.022","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein thrombosis: a case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}